MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Kindred Biosciences Company Profile (NYSE:KIN)

Consensus Ratings for Kindred Biosciences (NYSE:KIN) (?)
Ratings Breakdown: 2 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $5.00 (51.52% upside)

Analysts' Ratings History for Kindred Biosciences (NYSE:KIN)
Show:
DateFirmActionRatingPrice TargetActions
11/17/2015BMO Capital MarketsDowngradeOutperform -> Market Perform$14.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015Roth CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Craig HallumDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Leerink SwannDowngradeOutperform -> Market Perform$11.25 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014BMO Capital MarketsReiterated RatingOutperform$19.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2014BMO Capital MarketsLower Price Target$30.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2014Leerink SwannLower Price Target$29.00 -> $11.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2014Roth CapitalLower Price Target$11.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2014Craig HallumInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2014Leerink SwannBoost Price Target$29.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2014Roth CapitalLower Price Target$18.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2014Leerink SwannInitiated CoverageOutperform$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2014Roth CapitalLower Price Target$25.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2014Roth CapitalDowngradeBuy -> Neutral$20.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014BMO Capital MarketsUpgradeMarket Perform -> Outperform$15.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/11/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha